Pharmaceutical Commercial Startup and First Product Launch in the US
A development-stage pharmaceutical company based outside the US made a gutsy decision to establish their own commercial operations and launch their first product completely on their own in the US, despite not having expertise in the country nor having pharmaceutical commercial experience. Not a small feat but certainly the reward appeared to be worth the […]
Global E-Business Division for a Major Pharma Company
A client was racing to develop a leading-edge, web-based communications tool that would allow all operating companies and global corporate functions to interact seamlessly between themselves and thought-leading physicians around the world.As a new and rapidly moving project with limited marketing staff, little had been done to refine the product offering or prepare the customers […]
Injecting Commercial Participation and Focus into Product Development
A world-leading pharmaceutical company wanted to increase the rigor by which the new product market planning function was carried out— a new concept at the time since marketing participation in product development was still an emerging idea in the pharmaceutical industry. Leisa Dennehy, founder of BioPharma Consultants, was an employee at this company and was […]
Business Development Deal Maximizes the Potential of a Waning Brand
A top brand in a world-leading pharmaceutical company’s portfolio was in the waning years of its product life cycle. Yet, despite its financial importance (4th largest brand in the Company), little had been done to develop an end-of-life management strategy. Leisa Dennehy, co-founder of BioPharma Consultants, was assigned as the Marketing Director for the category. […]
Revamped Sales Strategy Leads to Increased Profitability
A major pharmaceutical company had a market leading brand late in its life cycle. The brand was considered a success, but had stalled in growth an profitability. Despite an increase in sales promotion, the brand’s revenue remained flat and the market share had been on the decline for several years. With still a few […]